Clinical Research Directory
Browse clinical research sites, groups, and studies.
Stereotactic Body Radiation Therapy With Immunotherapy for the Treatment of Mesothelioma
Sponsor: Mayo Clinic
Summary
This phase I trial studies the effect of stereotactic body radiation therapy and immunotherapy in treating patients with mesothelioma. Stereotactic body radiation therapy uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses over a shorter period and cause less damage to normal tissue. Giving stereotactic body radiation therapy and immunotherapy may improve the tumors response to the treatment and decrease side-effects.
Official title: SBRT With Immunotherapy for Mesothelioma
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2021-07-12
Completion Date
2026-05-25
Last Updated
2025-10-22
Healthy Volunteers
No
Conditions
Interventions
Immunotherapy
Immunotherapy
Quality-of-Life Assessment
Ancillary studies
Stereotactic Body Radiation Therapy
Undergo SBRT
Locations (1)
Mayo Clinic in Rochester
Rochester, Minnesota, United States